Form 4 holding
CEO and Chairman, Director, 10%+ Owner
Kairos Pharma, LTD.
- Security class
- COMMON STOCK
- Shares / value
- 5,316,572
- Estimated value
- $5,848,229
- Report date
- 08 Oct 2025
- Price
- $1.10
- Ownership
- By Self as Trustee for The Yu Family Trust